Zevra Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36.2M | 34.1M | 26.1M | 25.9M | 20.4M | 12.0M | 3.7M | 4.4M |
| Cost of Goods Sold | 2.3M | 1.5M | 1.6M | 12.4M | 1.3M | 1.4M | 2.3M | 3.6M |
| Gross Profit | 34.0M | 32.6M | 24.5M | 13.5M | 19.1M | 10.7M | 1.4M | 876K |
| R&D Expenses | 4.4M | 2.6M | 3.4M | 3.4M | 3.3M | 9.9M | 10.9M | 10.5M |
| Operating Expenses | 25.2M | 23.3M | 20.4M | 84.5M | 24.4M | 26.1M | 28.7M | 24.7M |
| Operating Income | 8.8M | 9.3M | 4.1M | -71.0M | -5.4M | -15.4M | -27.3M | -23.8M |
| Other Income / Gains | 36.0M | 3.4M | -5.1M | 147.9M | 3.4M | -5.0M | -5.9M | 3.9M |
| Net Income | 37.9M | 12.2M | -544K | 74.7M | -3.1M | -35.7M | -33.2M | -19.9M |
| EPS (Diluted) | 0.62 | 0.21 | -0.01 | 1.36 | -0.057 | -0.67 | -0.69 | -0.48 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.937 | 0.955 | 0.94 | 0.522 | 0.934 | 0.887 | 0.377 | 0.197 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 1.6M | 0 | 1.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 14.5M | 0 | 11.0M |
| Selling General And Administrative Expenses | 20.8M | 20.4M | 16.9M | 20.8M | 19.5M | 16.1M | 16.2M | 12.6M |
| Other Expenses | 0 | 316K | 0 | 60.3M | 1.6M | 54K | 1.5M | 1.5M |
| Cost And Expenses | 27.4M | 24.8M | 21.9M | 96.9M | 25.8M | 27.5M | 31.0M | 28.2M |
| Interest Income | 0 | 1.7M | 0 | 0 | 543K | -73K | 1.0M | 270K |
| Interest Expense | -1.7M | 1.9M | 2.1M | 2.0M | 2.0M | 2.2M | 2.3M | 2.1M |
| Depreciation And Amortization | 368K | 362K | 392K | 1.7M | 1.6M | 1.6M | 1.6M | 1.6M |
| Ebitda | 9.2M | 15.0M | 1.5M | 80.6M | 1.7M | -16.5M | -29.3M | -16.2M |
| Ebitdaratio | 0.254 | 0.439 | 0.056 | 3.113 | 0.083 | -1.372 | -7.929 | -3.637 |
| Operating Income Ratio | 0.244 | 0.273 | 0.159 | -2.745 | -0.263 | -1.28 | -7.39 | -5.348 |
| Income Before Tax | 44.8M | 12.7M | -977K | 76.9M | -1.9M | -20.4M | -33.2M | -19.9M |
| Income Before Tax Ratio | 1.237 | 0.371 | -0.037 | 2.972 | -0.094 | -1.691 | -8.992 | -4.463 |
| Income Tax Expense | 6.9M | 501K | -433K | 2.2M | 1.2M | 15.4M | 0 | 70K |
| Net Income Ratio | 1.046 | 0.356 | -0.021 | 2.887 | -0.152 | -2.968 | -8.992 | -4.479 |
| Epsdiluted | 0.60 | 0.20 | -0.01 | 1.36 | -0.057 | -0.67 | -0.69 | -0.48 |
| Weighted Average Shs Out | 58.4M | 55.3M | 56.0M | 54.8M | 54.1M | 53.7M | 47.8M | 41.9M |
| Weighted Average Shs Out Dil | 60.2M | 57.3M | 56.0M | 56.3M | 54.1M | 53.7M | 47.8M | 41.9M |